Rigel Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
3.66
|
|
Average Rating
|
3.57
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.13
|
-0.11
|
0.02
|
15.38%
|
|
2022-06-30
|
-0.12
|
-0.08
|
0.04
|
33.33%
|
|
2022-03-31
|
-0.14
|
-0.16
|
-0.02
|
-14.29%
|
|
2021-12-31
|
-0.13
|
-0.13
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.10
|
-0.12
|
-0.02
|
-20.00%
|
|
2021-06-30
|
-0.11
|
-0.08
|
0.03
|
27.27%
|
|
2021-03-31
|
0.01
|
0.22
|
0.21
|
2100.00%
|
|
2020-12-31
|
-0.11
|
-0.11
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.35
|
|
2021-12-31
|
-0.11
|
|
2020-12-31
|
-0.16
|
|
2019-12-31
|
-0.40
|
|
2018-12-31
|
-0.44
|
|
2017-12-31
|
-0.61
|
|
2016-12-31
|
-0.74
|
|
2015-12-31
|
-0.59
|
|
2014-12-31
|
-0.93
|
|
2013-12-31
|
-0.99
|
|
2012-12-31
|
-1.33
|
|
2011-12-31
|
-1.38
|
|
2010-12-31
|
0.71
|
|
2009-12-31
|
-2.81
|
|
2008-12-31
|
-3.66
|
|
2007-12-31
|
-2.58
|
|
2006-12-31
|
-1.51
|
|
2005-12-31
|
-2.11
|
|
2004-12-31
|
-3.12
|
|
2003-12-31
|
-5.02
|
|
2002-12-31
|
-7.38
|
|
2001-12-31
|
-5.76
|
|
2000-12-31
|
-3.24
|